Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_assertion type Assertion NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_head.
- NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_assertion description "[Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_provenance.
- NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_assertion evidence source_evidence_literature NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_provenance.
- NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_assertion SIO_000772 17405907 NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_provenance.
- NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_assertion wasDerivedFrom befree-20140225 NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_provenance.
- NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_assertion wasGeneratedBy ECO_0000203 NP373332.RAScl6mAOg0tomTLOjXgZKnTIGAXPiLUx0SRKcmlJfzH0130_provenance.